Intraoperative electron-beam radiotherapy and ureteral obstruction

Robert C. Miller, Michael Haddock, Ivy A Petersen, Leonard L. Gunderson, Alfred F. Furth

Research output: Contribution to journalArticle

13 Citations (Scopus)

Abstract

Purpose: To quantify the risk of ureteral obstruction (UO) after intraoperative electron-beam radiotherapy (IOERT). Methods and Materials: One hundred forty-six patients received IOERT of 7.5 to 30 Gy to 168 ureters; 132 patients received external radiotherapy. Results: Follow-up ranged from 0.01 to 19.1 years (median, 2.1 years). The rates of clinically apparent type 1 UO (UO from any cause) after IOERT at 2, 5, and 10 years were 47%, 63%, and 79%, respectively. The rates of clinically apparent type 2 UO (UO occurring at least 1 month after IOERT, excluding UO caused by tumor or abscess and patients with stents) at 2, 5, and 10 years were 27%, 47%, and 70%, respectively. Multivariate analysis revealed that the presence of UO before IOERT (p < 0.001) was associated with an increased risk of clinically apparent type 1 UO. Increasing IOERT dose (p < 0.04) was associated with an increased risk of clinically apparent type 2 UO. UO rates in ureters not receiving IOERT at 2, 5, and 10 years were 19%, 19%, and 51%, respectively. Conclusions: Risk of UO after IOERT increases with dose. However, UO risk for ureters not receiving IOERT was also high, which suggests an underlying risk of ureteral injury from other causes.

Original languageEnglish (US)
Pages (from-to)792-798
Number of pages7
JournalInternational Journal of Radiation Oncology Biology Physics
Volume64
Issue number3
DOIs
StatePublished - Mar 1 2006

Fingerprint

Ureteral Obstruction
radiation therapy
Radiotherapy
electron beams
Electrons
Ureter
dosage
causes
tumors
Abscess
Stents
Multivariate Analysis

Keywords

  • Intraoperative radiotherapy
  • Side effects
  • Ureter

ASJC Scopus subject areas

  • Oncology
  • Radiology Nuclear Medicine and imaging
  • Radiation

Cite this

Intraoperative electron-beam radiotherapy and ureteral obstruction. / Miller, Robert C.; Haddock, Michael; Petersen, Ivy A; Gunderson, Leonard L.; Furth, Alfred F.

In: International Journal of Radiation Oncology Biology Physics, Vol. 64, No. 3, 01.03.2006, p. 792-798.

Research output: Contribution to journalArticle

@article{7553e41dcfb84a14b523a1d4aac612ae,
title = "Intraoperative electron-beam radiotherapy and ureteral obstruction",
abstract = "Purpose: To quantify the risk of ureteral obstruction (UO) after intraoperative electron-beam radiotherapy (IOERT). Methods and Materials: One hundred forty-six patients received IOERT of 7.5 to 30 Gy to 168 ureters; 132 patients received external radiotherapy. Results: Follow-up ranged from 0.01 to 19.1 years (median, 2.1 years). The rates of clinically apparent type 1 UO (UO from any cause) after IOERT at 2, 5, and 10 years were 47{\%}, 63{\%}, and 79{\%}, respectively. The rates of clinically apparent type 2 UO (UO occurring at least 1 month after IOERT, excluding UO caused by tumor or abscess and patients with stents) at 2, 5, and 10 years were 27{\%}, 47{\%}, and 70{\%}, respectively. Multivariate analysis revealed that the presence of UO before IOERT (p < 0.001) was associated with an increased risk of clinically apparent type 1 UO. Increasing IOERT dose (p < 0.04) was associated with an increased risk of clinically apparent type 2 UO. UO rates in ureters not receiving IOERT at 2, 5, and 10 years were 19{\%}, 19{\%}, and 51{\%}, respectively. Conclusions: Risk of UO after IOERT increases with dose. However, UO risk for ureters not receiving IOERT was also high, which suggests an underlying risk of ureteral injury from other causes.",
keywords = "Intraoperative radiotherapy, Side effects, Ureter",
author = "Miller, {Robert C.} and Michael Haddock and Petersen, {Ivy A} and Gunderson, {Leonard L.} and Furth, {Alfred F.}",
year = "2006",
month = "3",
day = "1",
doi = "10.1016/j.ijrobp.2005.08.019",
language = "English (US)",
volume = "64",
pages = "792--798",
journal = "International Journal of Radiation Oncology Biology Physics",
issn = "0360-3016",
publisher = "Elsevier Inc.",
number = "3",

}

TY - JOUR

T1 - Intraoperative electron-beam radiotherapy and ureteral obstruction

AU - Miller, Robert C.

AU - Haddock, Michael

AU - Petersen, Ivy A

AU - Gunderson, Leonard L.

AU - Furth, Alfred F.

PY - 2006/3/1

Y1 - 2006/3/1

N2 - Purpose: To quantify the risk of ureteral obstruction (UO) after intraoperative electron-beam radiotherapy (IOERT). Methods and Materials: One hundred forty-six patients received IOERT of 7.5 to 30 Gy to 168 ureters; 132 patients received external radiotherapy. Results: Follow-up ranged from 0.01 to 19.1 years (median, 2.1 years). The rates of clinically apparent type 1 UO (UO from any cause) after IOERT at 2, 5, and 10 years were 47%, 63%, and 79%, respectively. The rates of clinically apparent type 2 UO (UO occurring at least 1 month after IOERT, excluding UO caused by tumor or abscess and patients with stents) at 2, 5, and 10 years were 27%, 47%, and 70%, respectively. Multivariate analysis revealed that the presence of UO before IOERT (p < 0.001) was associated with an increased risk of clinically apparent type 1 UO. Increasing IOERT dose (p < 0.04) was associated with an increased risk of clinically apparent type 2 UO. UO rates in ureters not receiving IOERT at 2, 5, and 10 years were 19%, 19%, and 51%, respectively. Conclusions: Risk of UO after IOERT increases with dose. However, UO risk for ureters not receiving IOERT was also high, which suggests an underlying risk of ureteral injury from other causes.

AB - Purpose: To quantify the risk of ureteral obstruction (UO) after intraoperative electron-beam radiotherapy (IOERT). Methods and Materials: One hundred forty-six patients received IOERT of 7.5 to 30 Gy to 168 ureters; 132 patients received external radiotherapy. Results: Follow-up ranged from 0.01 to 19.1 years (median, 2.1 years). The rates of clinically apparent type 1 UO (UO from any cause) after IOERT at 2, 5, and 10 years were 47%, 63%, and 79%, respectively. The rates of clinically apparent type 2 UO (UO occurring at least 1 month after IOERT, excluding UO caused by tumor or abscess and patients with stents) at 2, 5, and 10 years were 27%, 47%, and 70%, respectively. Multivariate analysis revealed that the presence of UO before IOERT (p < 0.001) was associated with an increased risk of clinically apparent type 1 UO. Increasing IOERT dose (p < 0.04) was associated with an increased risk of clinically apparent type 2 UO. UO rates in ureters not receiving IOERT at 2, 5, and 10 years were 19%, 19%, and 51%, respectively. Conclusions: Risk of UO after IOERT increases with dose. However, UO risk for ureters not receiving IOERT was also high, which suggests an underlying risk of ureteral injury from other causes.

KW - Intraoperative radiotherapy

KW - Side effects

KW - Ureter

UR - http://www.scopus.com/inward/record.url?scp=31844451003&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=31844451003&partnerID=8YFLogxK

U2 - 10.1016/j.ijrobp.2005.08.019

DO - 10.1016/j.ijrobp.2005.08.019

M3 - Article

C2 - 16243445

AN - SCOPUS:31844451003

VL - 64

SP - 792

EP - 798

JO - International Journal of Radiation Oncology Biology Physics

JF - International Journal of Radiation Oncology Biology Physics

SN - 0360-3016

IS - 3

ER -